全文获取类型
收费全文 | 36790篇 |
免费 | 3077篇 |
国内免费 | 1124篇 |
专业分类
耳鼻咽喉 | 453篇 |
儿科学 | 748篇 |
妇产科学 | 334篇 |
基础医学 | 8097篇 |
口腔科学 | 363篇 |
临床医学 | 3562篇 |
内科学 | 4991篇 |
皮肤病学 | 527篇 |
神经病学 | 2521篇 |
特种医学 | 857篇 |
外国民族医学 | 18篇 |
外科学 | 3035篇 |
综合类 | 5855篇 |
现状与发展 | 5篇 |
预防医学 | 2284篇 |
眼科学 | 403篇 |
药学 | 2775篇 |
18篇 | |
中国医学 | 612篇 |
肿瘤学 | 3533篇 |
出版年
2024年 | 26篇 |
2023年 | 478篇 |
2022年 | 708篇 |
2021年 | 1252篇 |
2020年 | 1225篇 |
2019年 | 1152篇 |
2018年 | 1047篇 |
2017年 | 1126篇 |
2016年 | 1273篇 |
2015年 | 1252篇 |
2014年 | 1874篇 |
2013年 | 2247篇 |
2012年 | 1728篇 |
2011年 | 1955篇 |
2010年 | 1461篇 |
2009年 | 1402篇 |
2008年 | 1436篇 |
2007年 | 1514篇 |
2006年 | 1379篇 |
2005年 | 1322篇 |
2004年 | 1220篇 |
2003年 | 1149篇 |
2002年 | 969篇 |
2001年 | 885篇 |
2000年 | 840篇 |
1999年 | 679篇 |
1998年 | 650篇 |
1997年 | 635篇 |
1996年 | 576篇 |
1995年 | 737篇 |
1994年 | 669篇 |
1993年 | 596篇 |
1992年 | 568篇 |
1991年 | 569篇 |
1990年 | 489篇 |
1989年 | 378篇 |
1988年 | 387篇 |
1987年 | 355篇 |
1986年 | 358篇 |
1985年 | 576篇 |
1984年 | 449篇 |
1983年 | 340篇 |
1982年 | 277篇 |
1981年 | 252篇 |
1980年 | 172篇 |
1979年 | 103篇 |
1978年 | 85篇 |
1977年 | 73篇 |
1976年 | 27篇 |
1975年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
王祥慧 《中华移植杂志(电子版)》2019,13(1):34-40
重点概述2018年美国移植大会及第27届国际移植大会有关器官移植基础、临床及转化医学研究的前沿热点及最新进展,包括供者特异性抗体、抗体介导排斥反应、临床免疫耐受、供器官合理利用、供肝保存新技术应用及移植相关病毒感染等概要内容。 相似文献
32.
33.
34.
Wenjing Tang Ying Dou Tao Qin Yuan Ding Xuemei Tang Xiaodong Zhao Yunfei An 《Scandinavian journal of immunology》2019,89(6)
DOCK8 immunodeficiency syndrome (DIDS) is a combined immunodeficiency characterized by recurrent viral infections, severe atopy and early onset malignancy. Immunological abnormalities include lymphopenia, CD8+ T‐cell cytoskeleton dysfunction, defective B cell memory and variable serum immunoglobulin levels. Here, we analyse the B cell receptor repertoire (BCR) characteristics and antibody avidity of four DIDS patients, attempt to understand the dysregulated humoral immunity in DIDS patients with a normal antibody titre and suggest a scientific basis for intravenous immunoglobulin (IVIG) replacement therapy for these patients. We analysed BCR characteristics, including somatic hypermutation (SHM) frequency, using deep sequencing of multiplex PCR products derived from BCR heavy chain CDR3 regions from DIDS patients and controls. The antibody avidity of human tetanus and hemophilus influenza B antibodies was determined by ELISA using thiocyanate elution. IVIG replacement treatment and infection conditions were investigated retrospectively. We found skewing of the BCR repertoire and decreased antibody avidity in patients with DIDS. DIDS patients had fewer negatively charged amino acids than healthy controls. The SHM frequency of the IGHV3 gene was lower in patients with DIDS. Patients received regular IVIG therapy, resulting in fewer and less severe infections. We conclude that although IgG levels are normal in most DIDS patients, IVIG replacement therapy is still necessary. 相似文献
35.
36.
�� �ģ�ۭ���� 《中国实用外科杂志》2019,39(3):197-199
甲状腺癌是最常见的内分泌肿瘤之一,其发病率逐年上升。对于复杂疑难的甲状腺癌,其诊断过程涉及超声、CT、放射性核素检查、喉镜检查、血液学检查[甲状腺功能、血清甲状腺球蛋白(Tg)]、病理学检查。其治疗是以外科为主的综合治疗,诊疗过程涉及甲状腺外科、耳鼻喉科、胸外科、麻醉科、内分泌科、核医学科、放疗科、肿瘤内科、ICU、超声科、病理科、影像科等。采用多学科综合治疗协作组(MDT)模式可以发挥多学科优势,为病人提供最佳的诊疗方案,实现个体化、精准化治疗,有助于降低手术并发症发生率,改善病人预后和生活质量,提高综合疗效,最终使甲状腺癌病人获益。 相似文献
37.
目的 探究原发灶定位与甲状腺乳头状微小癌(PTMC)颈侧区淋巴结转移的关系,评估超声检查预测颈侧区淋巴结转移的准确率。方法 回顾性分析2014年1月至2015年12月天津医科大学肿瘤医院收治的134例PTMC病人的临床资料,均行中央区淋巴结清扫+改良颈侧区淋巴结清扫。依据超声定位分组,分析癌灶位置与颈侧区淋巴结转移的关系。结果 颈侧各分区淋巴结转移发生率分别为:Ⅱ区30.6%、Ⅲ区50.7%、Ⅳ区57.5%、Ⅴ区11.3%。癌灶位于中上极者颈侧区淋巴结转移发生率高于癌灶位于下极者(89.7% vs. 75.7%,P=0.038),靠近外侧者较内侧者更易出现颈侧区淋巴结转移(93.7% vs. 81.4%,P=0.049)。超声检查判定Ⅱ、Ⅲ、Ⅳ、Ⅴ区淋巴结转移的敏感度分别为43.9%、85.3%、85.7%、14.3%;特异度为91.4%、57.6%、35.1%、99.1%。超声预测Ⅲ、Ⅳ区淋巴结转移敏感度较高,Ⅱ、Ⅴ区淋巴结转移特异度较高。结论 癌灶位置与甲状腺微小癌颈侧区淋巴结转移密切相关,超声可为临床确定颈侧区淋巴结的清扫范围提供依据。 相似文献
38.
39.
40.
《Vaccine》2019,37(41):6060-6067
BackgroundVaccination provides protection against infection by inducing VNAs mainly against RABV surface GP. The measurement of VNAs to RABV is commonly used to assess the level of immunity in humans and animals after vaccination. A VNA titer of ≥ 0.5 IU/mL of sera indicates adequate response to vaccination. Here, we report the development and validation of a RABV GP serology ELISA kit for semi-quantitative measurement of VNA titers in sera of vaccinated human subjects.MethodsUsing a recombinant RABV GP expressed in mammalian cells as the capture antigen, the ELISA method was established using HuMAb NM57 reference initially and HRIG reference subsequently. The limit of detection (LOD), linear range, reproducibility, and precision of the method were examined. Specificity and sensitivity were established to assess the diagnostic accuracy.ResultsRABV GP for ELISA plate coating and optimal dilution of human serum sample was 1 µg/mL and 1:20, respectively. Multiple assays were carried out by different technicians at different laboratories for assay standardization. Using the HRIG reference, the LOD was found to be 0.02–0.06 IU/mL and the linear range was 0.2–10.0 IU/ mL. The inter-assay CVs were in the range of 6.60–10.79%, indicating the reproducibility. None of the 12 known negative human sera, tested positive by ELISA, highlighting the specificity. A total of 415 unknown positive human sera were double-blind tested by the RFFIT and ELISA. The VNA titer cut-off value of ELISA was set at 1.5 IU/mL to ensure no false-positive. The diagnostic specificity and sensitivity were 100% and 91.1%, respectively.ConclusionsThe validation data characterize this ELISA as a suitable method for semi-quantitative measurement of VNA titers in human serum samples to assess vaccination status. The ELISA kit can offer simplicity, speed, low cost and high throughput, making it a practical tool for monitoring the immune response following vaccination. 相似文献